Hyponatraemia in clinical practice

Postgraduate Medical Journal

Volumn 83, Issue 980, 2007, Pages 373-378

  Biswas, M ^b   Davies, J S ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; CENTRAL PONTINE MYELINOLYSIS; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; CLINICAL PRACTICE; HORMONE SUBSTITUTION; HUMAN; HYPERVOLEMIA; HYPONATREMIA; REVIEW; SYMPTOMATOLOGY; TIME;

ACUTE DISEASE; CHRONIC DISEASE; FORECASTING; HUMANS; HYPONATREMIA; SODIUM; WATER-ELECTROLYTE IMBALANCE;

EID: 34250723746     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2006.056515     Document Type: Review

References (32)

1. Reynolds R, Secki JR. Hyponatraemia for the clinical endocrinologist. Clin Endocrinol (Oxf) 2005;63:366-74.
2. Sterns RH, Cappucio JD, Silver SM, et al. Neurologic sequelae after treatment of severe hyponatremia: a multicentre perspective. J Am Soc Nephrol 1994;8:1522-30.
3. Kunhle U, Lewicka S, Fuller PJ. Endocrine disorders of sodium regulation. Horm Res 2004;61:68-83.
4. Gennari FJ. Serum osmolality: uses and limitations. N Engl J Med 1984;310:102-5.
5. Kumar S, Beri T. Sodium. Lancet 1998;352:220-8.
6. Adrogue H, Madias NE. Hyponatremia. N Engl J Med 2000;342:1581-9.
7. Ishikawa S, Schrier R. Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin Endocrinol (Oxf) 2003;58:1-17.
8. Seckl JR, Williams TD, Lightman SL. Oral hypertonic saline causes transient fall of vasopressin in humans. Am J Physiol 1986;251:R214-17.
9. Agarwal R, Emmett M. The post-transurethral resection of prostate syndrome: therapeutic proposals. Am J Kidney Dis 1994;24:108-11.
10. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia evaluating the correction factor for hyperglycaemia. Am J Med 1999;106:399-403.
11. Scwartz WB, Bennett W, Curelop S, et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of anti-diuretic hormone. Am J Med 1957;13:529-42.
12. Peters JP, Welt LG, Sims EA, et al. A salt-wasting syndrome associated with cerebral disease. Trans Assoc Am Physicians 1950;63:57-64.
13. Sivakumar V, Rajshekar V, Chandy MJ. Management of neurosurgical patients with hyponatraemia and natriuresis. Neurosurgery 1994;34:269-74.
14. Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997;349:245-9.
15. Harrigan MR. Cerebral salt wasting syndrome: a review. Neurosurgery 1996;38:152-60.
16. Oren RM. Hyponatremia in congestive heart failure. Am J Cardiol 2005;95(95A):2B-7B.
17. Anderson RJ, Chung HM, Kluge R, et al. Hyponatraemia: a prospective analysis of its epidemiology and the role of vasopressin. Ann Intern Med 1985;102:164-8.
18. Hilden T, Svendsen TL. Electrolyte disturbances in beer drinkers. A specific hypoosmolality syndrome. Lancet 1975;2:245-6.
19. Goldman MB, Robertson GL, Luchins DJ, et al. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 1997;54:443-9.
20. Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychol 1988;145:675-83.
21. Almond CS, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Boston marathon. N Engl J Med 2005;352:1550-6.
22. Frizelle FA, Colls BM. Hyponatraemia and seizures after bowel preparation: report of 3 cases. Dis Colon Rectum 2005;48:393-6.
23. Diederich S, Franzen N. F, Bähr V, et al. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases, Eur J Endocrinol 2003;148:609-17.
24. Arieff AI, Guisado R. Effects on the central nervous system of hypernatraemic and hyponatraemic states. Kidney Int 1976;10:104-6.
25. Arieff A, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatraemia: correlation with brain water and electrolytes. Medicine 1976;55:121-9.
26. Karp B, Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatraemia. Medicine 1993;72:359-73.
27. Adrogue HJ, Madias NE. Aiding fluid prescription for the dysnatraemias. Intensive Care Med 1997;23:309-16.
28. Liamis G, Kalogirou M, Saugos V, et al. Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant 2006;21:1564-9.
29. Castello L, Pirisi M, Sainagh PP, et al. Quantative treatment of the hyponatraemia of cirrhosis. Dig Liver Dis 2005;37:176-80.
30. Gerbes A, Gulberg, V, Gines P, et al. Therapy of hyponatraemia in cirrhosis with a vasopressin receptor antagonist: a randomised double blind multicentre trial. Gastroenterology 2003;124:933-9.
31. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2 receptor antagonist for hyponatremia. N Engl J Med 2006;355:2099-112.
32. Udelson JE, Smith WB, Hendrix GH, et al. Acute haemodynamic effects of conivaptan, a dual V1a and V2 vasopressin receptor antagonist in patients with advanced heart failure. Circulation 2001;104:2417- 23.